Recombinant Proteins Market - Top Companies and Manufacturers

Companies Dominating the Recombinant Proteins Landscape

Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Merck KGaA
Lonza Group AG
GenScript Biotech Corporation
AbbVie Inc.
Amgen Inc.
Roche Holdings Inc.
Novartis AG
Pfizer Inc.
Sanofi SA

Browse Key Market Insights with Data Illustration:

Recombinant Proteins Market Size & Share, Growth Forecasts 2037

In the News

Merck KGaA: Merck announced that it had signed an agreement to acquire AmpTec, a leading provider of high-quality RNA and mRNA for research and commercial applications. The acquisition will strengthen Merck's capabilities in the field of mRNA-based therapeutics and vaccines.
Roche Holdings Inc.: Roche announced that it had received approval from the US Food and Drug Administration (FDA) for its recombinant protein Hemlibra, for the treatment of hemophilia A in patients without factor VIII inhibitors. Hemlibra is a bispecific antibody designed to bring together factors IXa and X, which are needed to activate the natural coagulation cascade and restore the blood clotting process.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of recombinant proteins is estimated at USD 2.81 billion.

The recombinant proteins market size was valued at USD 2.55 billion in 2024 and is expected to cross USD 12.17 billion by the end of 2037, registering more than 12.7% CAGR during the forecast period i.e., between 2025-2037. Increasing investments in development of biopharmaceuticals and recombinant proteins, and growing prevalence of genetic rare diseases will boost the market growth.

North America is predicted to hold largest industry share of about 35% by 2037, attributed to growing population and research activity, health insurance covering various cancer diagnoses and related treatments requiring recombinant proteins.

The major players in the market include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, GenScript Biotech Corporation, AbbVie Inc., Amgen Inc., Roche Holdings Inc., Novartis AG, Pfizer Inc., Sanofi SA.

Recombinant Proteins Market - Top Companies and Manufacturers

Companies Dominating the Recombinant Proteins Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the recombinant proteins market?

Why is the recombinant proteins sector gaining traction in near future?

Which region accounted for the largest recombinant proteins industry share?

Who are the major recombinant proteins players?